Endocannabinoid Analogs as Anti-inflammatory Agents
Endocannabinoid Analogs as Anti-inflammatory Agents
批准号:
7678732
负责人:
SUMNER HOWARD BURSTEIN
金额:
$2.92万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-30 至 2009-07-31
关键词:
Absence of pain sensationAcidsAmidesAmino AcidsAnalgesicsAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntihypertensive AgentsBehaviorBiologicalBiological AssayCognitionComputer AssistedDataDockingDrug AddictionElevationEndocannabinoidsEnzymesExposure toFamilyFatty AcidsGoalsHealthHumanIL8 geneImmune responseIn VitroInflammation MediatorsInflammatory ResponseMediator of activation proteinMembraneMemoryModelingMotor ActivityN-arachidonylglycineNumbersPTGS2 genePainPerceptionPregnancyPreparationProcessPropertyPublishingRangeRegulationReportingRoleSeriesSerine HydrolaseSleepStructureSuggestionTestingTissuesWakefulnessanaloganandamidebasecell growthcell typeenantiomerimplantationin vivoin vivo Modelinhibitor/antagonistinterestmember
中文摘要
内源性大麻素anandamide(花生四烯醇基乙醇酰胺)是一个调节家族的主要成员,参与调节许多生物行为,包括镇痛和炎症反应的特定方面。有人认为,苯胺的酸性同系物可能作为内源性物质存在。这一假设在一项研究中得以实现,该研究表明,这种物质n -花生四烯酰甘氨酸(NAGly)确实是许多组织的内源性成分,其含量高于anandamide。NAGly的一个有趣的特性是它对FAAH的有效抑制作用,FAAH是主要负责终止anandamide作用的酶。FAAH是一种丝氨酸水解酶,其晶体
英文摘要
The endocannabinoid anandamide (arachidonyl ethanolamide) is the principal member of a family of regulators that are involved in modulating a number of biological actions including analgesia and specific aspects of the inflammatory response. It has been suggested that acid congeners of anandamide could exist as endogenous substances. This hypothesis was realized in a study that showed that such a substance, N-arachidonylglycine (NAGly), is indeed an endogenous constituent of many tissues and occurs at levels higher than anandamide. An interesting property of NAGly is its potent inhibitory effect on FAAH, the enzyme primarily responsible for the termination of anandamide action. FAAH is a serine hydrolase whose crystal
structure was recently published, thus, opening the way for the rational study of the structural features of NAGly that confer its inhibitory properties. It has been reported that NAGly treatment in both in vitro and in vivo models, leads to a robust increase in anandamide concentrations. We therefore hypothesize that this inhibitory action is the basis for the anti-inflammatory action of NAGly and possibly other actions, e.g. analgesia. A major goal of this project is to synthesize a series of NAGly analogs as probes; these will be based on computer assisted docking analysis using the crystal structure of FAAH. The analogs will be tested in vitro as inhibitors of FAAH and compared with their effects on mediators of inflammation. The structure-activity data that will emerge from these studies will either support or refute the hypothesis.
Anandamide appears to be involved in a wide range of regulatory functions through out the animal kingdom. Some examples are: the control of sensorimotor and motivational aspects of behavior, the regulation of implantation, hypotensive and bradycardic effects, cognition and drug dependence, the control of human pregnancy, sleep- wakefulness cycle, memory formation, locomotor activity, pain perception and modulation of the immune response. Thus, agents such as NAGly that can regulate in vivo anandamide levels could be effective modulators of many of these health related processes.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
The elmiric acids: biologically active anandamide analogs.
-
批准号:7727687
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2009
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
The elmiric acids: biologically active anandamide analogs.
-
批准号:7894890
-
项目类别:
-
资助金额:$32.43万
-
财政年份:2009
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
Endocannabinoid Analogs as Anti-inflammatory Agents
-
批准号:7106374
-
项目类别:
-
资助金额:$11.86万
-
财政年份:2004
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
Endocannabinoid Analogs as Anti-inflammatory Agents
-
批准号:6951593
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2004
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
Endocannabinoid Analogs as Anti-inflammatory Agents
-
批准号:6749403
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2004
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
-
批准号:6175550
-
项目类别:
-
资助金额:$23.86万
-
财政年份:1999
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
-
批准号:2902241
-
项目类别:
-
资助金额:$23.17万
-
财政年份:1999
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
-
批准号:6378830
-
项目类别:
-
资助金额:$24.58万
-
财政年份:1999
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
-
批准号:6515659
-
项目类别:
-
资助金额:$25.2万
-
财政年份:1999
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
-
批准号:2122673
-
项目类别:
-
资助金额:$16.13万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2121953
-
项目类别:
-
资助金额:$15.04万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2377395
-
项目类别:
-
资助金额:$15.44万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2882593
-
项目类别:
-
资助金额:$16.7万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
-
批准号:2122674
-
项目类别:
-
资助金额:$16.57万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2668143
-
项目类别:
-
资助金额:$16.06万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2121952
-
项目类别:
-
资助金额:$15.03万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
-
批准号:2443494
-
项目类别:
-
资助金额:$17.23万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
PROSTAGLANDIN & CANNABIS
-
批准号:2116494
-
项目类别:
-
资助金额:$5.54万
-
财政年份:1977
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
PROSTAGLANDIN & CANNABIS
-
批准号:3207098
-
项目类别:
-
资助金额:$6.9万
-
财政年份:1977
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
BIOLOGICAL ACTIVITIES OF CANNABINOIDS
-
批准号:3207107
-
项目类别:
-
资助金额:$16.12万
-
财政年份:1977
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
抗禾谷镰刀菌3-Decalinoyltetramic Acids类天然产物的挖掘及基于“靶标垂钓”策略的作用机制研究
-
批准号:32470420
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2024
-
负责人:赵栋霖
-
依托单位:
真菌中同一PKS-NRPS基因簇合成两种不同骨架tetramic acids机制研究
-
批准号:32470051
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2024
-
负责人:张伟
-
依托单位:
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: